SHARE
Respiratory Diagnostics Market

Respiratory Diagnostics - Global Market Outlook (2020 -2028)

4.8 (56 reviews)
Published: April 2021 ID: SMRC20422
4.8 (56 reviews)
Published: April 2021 ID: SMRC20422

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Respiratory Diagnostics Market is accounted for $6.94 billion in 2020 and is expected to reach $14.14 billion by 2028 growing at a CAGR of 9.3% during the forecast period. The rising prevalence of respiratory diseases and technological advancements are the major factors propelling market growth. However, reimbursement concerns are hampering market growth.

Respiratory diagnostics have a principal part in the therapeutic innovation area. It involves the clinical assessment of some kinds of respiratory conditions such as bronchitis, asthma, COPD, pulmonary fibrosis among others by using various kinds of mechanical, imaging, and molecular diagnostics tests.

Based on the test type, the traditional diagnostic tests segment is estimated to have a lucrative growth due to it is widely used by developing countries and the fast working time of these tests allows patients to get effective results in a shorter period which further improves treatment procedures.

By geography, North America is going to have a lucrative growth during the forecast period due to the increasing prevalence of respiratory diseases and the growing anti-aging population. The U.S. dominates North America's respiratory diagnostics market due to its advanced healthcare system and strong distribution channels.

Some of the key players profiled in the Respiratory Diagnostics Market include Abbott Diagnostics Inc., Becton, Dickinson and Company, CAREstream Medical Ltd., Fisher & Paykel Healthcare, Inc., GE Healthcare Limited, Koninklijke Philips N.V, Medtronic, Inc., MGC Diagnostics Corporation, ResMed Inc., Thermo Fisher Scientific Inc., 3M, Philips Healthcare, Biomérieux, COSMED, Bio-Rad Laboratories Inc., SDI Diagnostics, Seegene Inc., and Alere Inc.
 
Test Types Covered:
• Imaging Tests
• Mechanical Tests
• Molecular Diagnostic Tests
• Traditional Diagnostic Tests

Product and Services Covered:
• Assays and Kits/Reagents
• Instruments and Devices
• Services and Software

Diseases Covered:
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Tuberculosis
• Other Diseases

Distribution Channels Covered:
• Retail Sales
• Direct Tender

End Users Covered:
• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Clinics
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary          
           
2 Preface          

 2.1 Abstract         
 2.2 Stake Holders         
 2.3 Research Scope         
 2.4 Research Methodology         
  2.4.1 Data Mining        
  2.4.2 Data Analysis        
  2.4.3 Data Validation        
  2.4.4 Research Approach        
 2.5 Research Sources         
  2.5.1 Primary Research Sources        
  2.5.2 Secondary Research Sources        
  2.5.3 Assumptions        
           
3 Market Trend Analysis          
 3.1 Introduction         
 3.2 Drivers         
 3.3 Restraints         
 3.4 Opportunities         
 3.5 Threats         
 3.6 Product Analysis          
 3.7 End User Analysis         
 3.8 Emerging Markets         
 3.9 Impact of Covid-19         
           
4 Porters Five Force Analysis          
 4.1 Bargaining power of suppliers         
 4.2 Bargaining power of buyers         
 4.3 Threat of substitutes         
 4.4 Threat of new entrants         
 4.5 Competitive rivalry         
           
5 Global Respiratory Diagnostics Market, By Test Type          
 5.1 Introduction         
 5.2 Imaging Tests         
  5.2.1 Computed Tomography        
  5.2.2 Magnetic Resonance Imaging (MRI)        
  5.2.3 Positron Emission Tomography (PET)        
  5.2.4 X-Ray        
 5.3 Mechanical Tests         
  5.3.1 Pulmonary Function Tests        
   5.3.1.1 Spirometry       
   5.3.1.2 Diffusion Capacity Test       
   5.3.1.3 Plethysmography Test       
  5.3.2 Peak Flow Test        
  5.3.3 Obstructive Sleep Apnoea (OSA) Diagnostic Tests        
   5.3.3.1 Polysomnography       
   5.3.3.2 Home Sleep Apnea Testing       
 5.4 Molecular Diagnostic Tests         
  5.4.1 Nucleic Acid Amplification Test        
  5.4.2 In Situ Hybridization        
  5.4.3 DNA Sequencing & Next-Generation Sequencing (NGS)        
  5.4.4 Microarrays        
  5.4.5 Polymerase Chain Reaction (PCR)        
 5.5 Traditional Diagnostic Tests         
  5.5.1 Biochemical Characterization        
  5.5.2 Microscopy        
  5.5.3 Immunodiagnostics        
           
6 Global Respiratory Diagnostics Market, By Product and Service          
 6.1 Introduction         
 6.2 Assays and Kits/Reagents         
 6.3 Instruments and Devices         
  6.3.1 Tabletop        
  6.3.2 Standalone        
  6.3.3 Portable        
 6.4 Services and Software         
           
7 Global Respiratory Diagnostics Market, By Disease          
 7.1 Introduction         
 7.2 Asthma         
 7.3 Chronic Obstructive Pulmonary Disease (COPD)         
 7.4 Lung Cancer         
 7.5 Tuberculosis         
 7.6 Other Diseases         
  7.6.1 Bronchitis         
  7.6.2 Pulmonary Fibrosis        
  7.6.3 Respiratory Infection        
           
8 Global Respiratory Diagnostics Market, By Distribution Channel          
 8.1 Introduction         
 8.2 Retail Sales         
 8.3 Direct Tender         
           
9 Global Respiratory Diagnostics Market, By End User          
 9.1 Introduction         
 9.2 Hospital/Clinical Laboratories         
 9.3 Physician Offices         
 9.4 Reference Laboratories         
 9.5 Clinics         
 9.6 Other End Users         
  9.6.1 Blood Banks        
  9.6.2 Point-Of-Care Testing        
  9.6.3 Patient Self-Testing        
           
10 Global Respiratory Diagnostics Market, By Geography          

 10.1 Introduction         
 10.2 North America          
  10.2.1 US        
  10.2.2 Canada        
  10.2.3 Mexico        
 10.3 Europe         
  10.3.1 Germany        
  10.3.2 UK        
  10.3.3 Italy        
  10.3.4 France        
  10.3.5 Spain        
  10.3.6 Rest of Europe        
 10.4 Asia Pacific         
  10.4.1 Japan        
  10.4.2 China        
  10.4.3 India        
  10.4.4 Australia        
  10.4.5 New Zealand        
  10.4.6 South Korea        
  10.4.7 Rest of Asia Pacific        
 10.5 South America          
  10.5.1 Argentina        
  10.5.2 Brazil        
  10.5.3 Chile        
  10.5.4 Rest of South America        
 10.6 Middle East & Africa         
  10.6.1 Saudi Arabia        
  10.6.2 UAE        
  10.6.3 Qatar        
  10.6.4 South Africa         
  10.6.5 Rest of Middle East & Africa        
           
11 Key Developments        
  
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures         
 11.2 Acquisitions & Mergers         
 11.3 New Product Launch         
 11.4 Expansions         
 11.5 Other Key Strategies         
           
12 Company Profiling       
   
 12.1 Abbott Diagnostics Inc.         
 12.2 Becton, Dickinson and Company         
 12.3 CAREstream Medical Ltd.         
 12.4 Fisher & Paykel Healthcare, Inc.         
 12.5 GE Healthcare Limited         
 12.6 Koninklijke Philips N.V         
 12.7 Medtronic, Inc.         
 12.8 MGC Diagnostics Corporation         
 12.9 ResMed Inc.         
 12.10 Thermo Fisher Scientific Inc.         
 12.11 3M         
 12.12 Philips Healthcare         
 12.13 Biomérieux         
 12.14 COSMED         
 12.15 Bio-Rad Laboratories Inc.         
 12.16 SDI Diagnostics         
 12.17 Seegene Inc.         
 12.18 Alere Inc.         


List of Tables           
1 Global Respiratory Diagnostics Market Outlook, By Region (2019-2028) ($MN)          
2 Global Respiratory Diagnostics Market Outlook, By Test Type (2019-2028) ($MN)          
3 Global Respiratory Diagnostics Market Outlook, By Imaging Tests (2019-2028) ($MN)          
4 Global Respiratory Diagnostics Market Outlook, By Computed Tomography (2019-2028) ($MN)          
5 Global Respiratory Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) (2019-2028) ($MN)          
6 Global Respiratory Diagnostics Market Outlook, By Positron Emission Tomography (PET) (2019-2028) ($MN)          
7 Global Respiratory Diagnostics Market Outlook, By X-Ray (2019-2028) ($MN)          
8 Global Respiratory Diagnostics Market Outlook, By Mechanical Tests (2019-2028) ($MN)          
9 Global Respiratory Diagnostics Market Outlook, By Pulmonary Function Tests (2019-2028) ($MN)          
10 Global Respiratory Diagnostics Market Outlook, By Peak Flow Test (2019-2028) ($MN)          
11 Global Respiratory Diagnostics Market Outlook, By Obstructive Sleep Apnoea (OSA) Diagnostic Tests (2019-2028) ($MN)          
12 Global Respiratory Diagnostics Market Outlook, By Molecular Diagnostic Tests (2019-2028) ($MN)          
13 Global Respiratory Diagnostics Market Outlook, By Nucleic Acid Amplification Test (2019-2028) ($MN)          
14 Global Respiratory Diagnostics Market Outlook, By In Situ Hybridization (2019-2028) ($MN)          
15 Global Respiratory Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (NGS) (2019-2028) ($MN)          
16 Global Respiratory Diagnostics Market Outlook, By Microarrays (2019-2028) ($MN)          
17 Global Respiratory Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2019-2028) ($MN)          
18 Global Respiratory Diagnostics Market Outlook, By Traditional Diagnostic Tests (2019-2028) ($MN)          
19 Global Respiratory Diagnostics Market Outlook, By Biochemical Characterization (2019-2028) ($MN)          
20 Global Respiratory Diagnostics Market Outlook, By Microscopy (2019-2028) ($MN)          
21 Global Respiratory Diagnostics Market Outlook, By Immunodiagnostics (2019-2028) ($MN)          
22 Global Respiratory Diagnostics Market Outlook, By Product and Service (2019-2028) ($MN)          
23 Global Respiratory Diagnostics Market Outlook, By Assays and Kits/Reagents (2019-2028) ($MN)          
24 Global Respiratory Diagnostics Market Outlook, By Instruments and Devices (2019-2028) ($MN)          
25 Global Respiratory Diagnostics Market Outlook, By Tabletop (2019-2028) ($MN)          
26 Global Respiratory Diagnostics Market Outlook, By Standalone (2019-2028) ($MN)          
27 Global Respiratory Diagnostics Market Outlook, By Portable (2019-2028) ($MN)          
28 Global Respiratory Diagnostics Market Outlook, By Services and Software (2019-2028) ($MN)          
29 Global Respiratory Diagnostics Market Outlook, By Disease (2019-2028) ($MN)          
30 Global Respiratory Diagnostics Market Outlook, By Asthma (2019-2028) ($MN)          
31 Global Respiratory Diagnostics Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2019-2028) ($MN)          
32 Global Respiratory Diagnostics Market Outlook, By Lung Cancer (2019-2028) ($MN)          
33 Global Respiratory Diagnostics Market Outlook, By Tuberculosis (2019-2028) ($MN)          
34 Global Respiratory Diagnostics Market Outlook, By Other Diseases (2019-2028) ($MN)          
35 Global Respiratory Diagnostics Market Outlook, By Bronchitis (2019-2028) ($MN)          
36 Global Respiratory Diagnostics Market Outlook, By Pulmonary Fibrosis (2019-2028) ($MN)          
37 Global Respiratory Diagnostics Market Outlook, By Respiratory Infection (2019-2028) ($MN)          
38 Global Respiratory Diagnostics Market Outlook, By Distribution Channel (2019-2028) ($MN)          
39 Global Respiratory Diagnostics Market Outlook, By Retail Sales (2019-2028) ($MN)          
40 Global Respiratory Diagnostics Market Outlook, By Direct Tender (2019-2028) ($MN)           
41 Global Respiratory Diagnostics Market Outlook, By End User (2019-2028) ($MN)          
42 Global Respiratory Diagnostics Market Outlook, By Hospital/Clinical Laboratories (2019-2028) ($MN)          
43 Global Respiratory Diagnostics Market Outlook, By Physician Offices (2019-2028) ($MN)          
44 Global Respiratory Diagnostics Market Outlook, By Reference Laboratories (2019-2028) ($MN)          
45 Global Respiratory Diagnostics Market Outlook, By Clinics (2019-2028) ($MN)          
46 Global Respiratory Diagnostics Market Outlook, By Other End Users (2019-2028) ($MN)          
47 Global Respiratory Diagnostics Market Outlook, By Blood Banks (2019-2028) ($MN)          
48 Global Respiratory Diagnostics Market Outlook, By Point-Of-Care Testing (2019-2028) ($MN)          
49 Global Respiratory Diagnostics Market Outlook, By Patient Self-Testing (2019-2028) ($MN)          
           
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.           

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials